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Crystal Structure of the Complex
between Calyculin A and the Catalytic
Subunit of Protein Phosphatase 1
and threonine residues of proteins in the cytosol of eu-
karyotic cells [1, 2]. These enzymes play critical roles in
determining the level of phosphorylation and, hence, the
biological activities of many proteins. There are several
naturally occurring toxins that are now widely used be-
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Graduate School of Science cause of their potent and specific actions to these struc-
turally related enzymes, showing 50% amino acid se-Kyoto University
Sakyo-ku, Kyoto 606-8502 quence identity in the catalytic domain [1, 2]. They
include okadaic acid [3], calyculin A [4], microcystin-LRJapan
2 Laboratory of Aquatic Natural Products Chemistry (MCLR) [5], and cantharidin [6] (Figure 1).
Among these inhibitors, calyculin A, initially isolatedGraduate School of Agricultural and Life Sciences
The University of Tokyo as a potent cytotoxin from the marine sponge Disco-
dermia calyx, has a unique structure, consisting of aBunkyo-ku, Tokyo 113-8657
Japan polyketide and a dipeptide with a phosphate group in the
polyketide portion [7]. A number of congeners have been3 Laboratory of Biomolecular Dynamics
Graduate School of Medicine reported from several sponges. Our recent study on the
structure-activity relationship (SAR) using nine naturalNagoya University
65 Tsurumai-cho congeners and six chemical derivatives of calyculin A
has identified several functional groups, such as theShowa-ku, Nagoya 466-8550
Japan phosphate group, the hydroxyl at C-13, and the hy-
drophobic polyketide tail, as essential for the inhibitory4 The Laboratory of Bioorganic Chemistry
Graduate School of Bioagricultural Science action of the toxin on the enzymes [8]. In contrast, the
dipeptide portion appears to be relatively unimportantNagoya University
Furo-cho, Nagoya 464-8601 for the interaction with the enzymes [8]. Several amino
acid residues of the enzymes important for the affinityJapan
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been identified by mutagenetic experiments [9–11].Koto 1-1-1
Mikazukicho X-ray crystallography of the catalytic subunit of PP1
(-isozyme; PP1) complexed with MCLR has providedSayo-gun, Hyogo 679-5148
Japan a detailed view of the interaction between the enzyme
and the toxin [12]. Several binding models for calyculin
A, as well as those for the other inhibitors, have been
proposed on the basis of this crystallographic struc-Summary
ture [13–17]. All such models postulated that calyc-
ulin A is accommodated into the binding pocket forThe crystal structure of the catalytic subunit of the
protein phosphatase 1 (PP1), PP1, in complex with a MCLR in such a way that the head component of calyc-
ulin A, including the aforementioned functional groups,marine toxin, calyculin A, was determined at 2.0 A˚
resolution. The metal binding site contains the phos- forms hydrogen bonds or indirect coordinate bonds with
the amino acid residues around the catalytic center,phate group of calyculin A and forms a tight network
via the hydrophilic interactions between PP1 and ca- whereas the nonpolar polyketide tail is docked in the
hydrophobic surface groove that directly extends fromlyculin A. Calyculin A is located in two of the three
grooves, namely, in the hydrophobic groove and the the catalytic center.
However, it should be noted that these models are stillacidic groove on the molecular surface. This is the
first observation to note that the inhibitor adopts not purely speculative. For example, no direct experimental
evidence indicating the existence of specific hydrogena pseudocyclic conformation but an extended confor-
mation in order to form a complex with the protein. bonds between the enzyme and calyculin A has been
available to date. Although calyculin A is known to adoptThe amino acid terminus of calyculin A contributes, in
a limited manner, to the binding to PP1, which is a pseudocyclic conformation by forming intramolecular
salt bridges and hydrogen bonds in the solid state asconsistent with findings from the studies of dose-inhi-
bition analysis. well as in the solution state in aprotic solvents [15, 18],
the overall conformation of calyculin A in the enzyme-
bound state remains for the most part uncertain due toIntroduction
its flexible backbone structure. Also, the basic hypothe-
sis of the models that calyculin A and the other phospha-Protein phosphatases 1 and 2A (PP1 and PP2A) are two
of the four major enzymes that dephosphorylate serine tase inhibitors share the same binding site with MCLR
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Figure 1. Structural Formulae of Calyculin A,
Hemicalyculin A, Okadaic Acid, MCLR, and
Cantharidin
should not be regarded as proven. This assumption is the reflections between 20.0 and 2.0 A˚ resolution, and
the free R factor dropped to 0.22 for 5% of the totalmainly based on the results of in vitro competition
assays that calyculin A and the other inhibitors bind reflections. The stereochemistry of the final model was
reasonable, with 88% residues lying within the mostto PP1 and PP2A in a mutually exclusive manner [19].
However, the exclusiveness of interactions could alter- favorable regions on the Ramachandran plot. The root-
mean-square (rms) deviations from the ideal values werenatively be explained by assuming that the binding of an
inhibitor causes a conformational change in the enzyme 0.007 A˚ for the bond lengths and 1.43 for the angles.
Superimposition of the C atoms of two PP1-calyculinmolecule, resulting in a decrease in its affinity to another
inhibitor at a different binding site. As we pointed out A molecules in an asymmetric unit shows an rmsd of
0.21 A˚. The statistics for data collection and refinementpreviously [19], it is logically impossible to completely
exclude such an alternative possibility by conventional are shown in Tables 1 and 2.
competition assays alone.
In the present study, we have determined the three- Overview of the PP1-Calyculin A Complex
dimensional structure of the complex between calyculin The catalytic subunit of PP1-calyculin A complex forms
A and the  isoform of PP1 (PP1) by X-ray crystallogra- an ellipsoidal structure, which consists of 10  helices
phy. The structure obtained shows that calyculin A is and 14  strands (Figure 2). On the molecular surface,
indeed accommodated in the surface groove of PP1, there are three grooves connected at the bifurcation
where MCLR is also bound. Calyculin A is docked onto point (Figure 3A). The calyculin A molecule was found
PP1with the binding mode of an extended form, which
is different from the crystal structure [18] and the solu-
tion structure of calyculin A [15]. Furthermore, the bound Table 1. Data Collection Statistics
conformation of calyculin A affords several key interac-
X-ray source BL44-B2 (SPring-8)
tions with the enzyme. Wavelength (A˚) 1.00
Temperature (K) 293
Resolution limit (A˚) 50–2.0
Results and Discussion Space group P21212
Unit cell dimensions (A˚) 98.1, 136.4, 61.6
Structure Determination Measured reflections 536,140
Unique reflections 56,530The PP1-calyculin A complex crystals were obtained
Redundancy 6.2from PEG 3350 solutions including 0.2 M potassium
Rmerge (%)a 7.8 (39.0)bsulfate as an additive by the sitting drop vapor diffusion
Completeness (%) 99.9 (99.6)b
method. The working R factor for the final model, includ-
aRmerge  (|I  I	|)/(I)ing residues 7–299 of two PP1 molecules, 4 metal
bThe values for the highest resolution shell (2.07–2.00 A˚) are in paren-atoms assigned as Mn (see below), 2 calyculin A mole-
thesis.
cules (N1–C32), and 96 water molecules, was 0.18 for
Crystal Structure of the PP1-Calyculin A Complex
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Table 2. Refinement Statistics
Resolution (A˚) 20.0–2.0
Rwork (%)/Rfree (%)a 18.2/21.8
Number of atoms
Protein 4724
Calyculin A 112
Metal 4
Solvent 96
Rms deviations from ideality
Bond length (A˚) 0.007
Bond angles () 1.43
Average B factors (A˚2)
Protein 21.0
Calyculin A 18.8
Metal 14.4
Solvent 25.2
Ramachandran statistics (%)
Most-favored regions 88.1
Additionally allowed regions 9.7
aR  ||Fobs|  |Fcalc||/|Fobs|.
Rwork is calculated from a set of reflections in which 5% of the total
reflections have been randomly omitted from the refinement used
to calculate Rfree.
at the grooves. The overall and secondary structures of
PP1 are similar to those of PP1-MCLR [12], PP1-
tungstate complex [20], and PP1-okadaic acid [21]
complex. Strong electron densities assumed to be metal
atoms were also found at the bifurcation point, where
the metal atoms were found in the PP1-MCLR struc-
ture. We assigned them as Mn atoms during the refine-
ment due to the presence of Mn in the purification and
crystallization procedures.
The groove in PP1-MCLR is an extended Y shape
that consists of a hydrophobic groove, an acidic groove,
and a C-terminal groove (Figure 3B). On the other hand,
the pathway to the C-terminal groove on the surface
of PP1-calyculin A complex is closed by the Cys273
Figure 3. The Molecular Surfaces of PP1-Calyculin A Complex and
PP1-MCLR
They are shown in color according to their electrostatic potentials
calculated by GRASP [43]: negatively charged surfaces, red; posi-
tively charged surfaces, blue. The charges of metals are assigned
as 
2. The orientation of the molecule is similar to that in Figure 2.
The three grooves are indicated by yellow arrows.
(A) The molecular surface of PP1-calyculin A complex.
(B) The molecular surface of PP1-MCLR.
belonging to the 12–13 loop (Figure 3A). C2–C32 of
Figure 2. The Overall Structure of PP1-Calyculin A Complex
calyculin A displayed very clear electron densities,
Schematic diagram of the three-dimensional structure of PP1, whereas the electron densities of the amino acid termi-
drawn by the program MOLSCRIPT [44], and rendered by RAS-
nus (C33–C37) of both calyculin A molecules in theTER3D [45]. The calyculin A molecule is shown in ball and stick
asymmetric unit were not so distinct. For the associationrepresentation. Colors are employed to identify the helices and
strands. Metal ions, gold circles; 12–13 loop, red. of PP1 with toxins and the inhibitors, the 12–13 loop
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Figure 4. Stereoviews of the 12–13 Loops and Inhibitors in PP1-Calyculin A Complex and in PP1-MCLR
The residues of Tyr272, Cys273, Glu275, and Phe276 of both proteins are represented by ball and stick models. Calyculin A and MCLR are
also represented by ball and stick models colored in yellow and green, respectively. The dashed black lines indicate the hydrogen bonds,
and the dashed yellow line indicates the covalent bond.
(A) The 12–13 loop in PP1-calyculin A complex.
(B) The 12–13 loop in PP1-MCLR.
is supposed to be essential [22]. The conformation of loops in PP1-calyculin A complex and PP1-MCLR are
shown together with their inhibitors in Figure 4. Only thethe 12–13 loop of PP1-calyculin A complex is similar
to that of PP1-okadaic acid complex [21], but not simi- Tyr272 residue interacted with the inhibitor in the PP1-
calyculin A 12–13 loop, while Tyr272 and Cys273 werelar to that of PP1-MCLR. The structures of the 12–13
Crystal Structure of the PP1-Calyculin A Complex
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Figure 5. Calyculin A Binding Site
Calyculin A, yellow.
(A) Stereoviews of the metal and phosphate group of the calyculin A binding site. Metal ions, gold; metal-liganded water oxygen atoms,
orange; other non-metal-liganded water molecules, small red circles. The dashed lines indicate the binding of two atoms, the orange dashed
lines indicate metal-ligand interactions, and the black dashed lines indicate other bonds.
(B) The interactions between calyculin A and residues belonging to PP1. The residues within 3.5 A˚ from calyculin A are shown. Residues
that form a hydrogen bond or salt bridge with calyculin A, purple. The black dashed lines indicate hydrogen bonds and salt bridges. The N1,
C50, C5, C49, and C10 atoms of calyculin A are marked in the figure.
shown to bind with the side chain of the inhibitor in atoms (M1 and M2). At the metal binding site, the phos-
PP1-MCLR. Cys273 in PP1-MCLR is covalently linked phate group of calyculin A, two ligand water molecules
to MCLR [12]. In the PP1-calyculin A complex, a large (W1 and W2), and three nonligand water molecules (W3,
electron density of S of Cys273 was observed. Cys273 W4, and W5) were observed (Figure 5A). M1 is coordi-
might be oxidized with a terminal sulfinyl group in PP1- nated by the four equatorial ligands provided by two
calyculin A complex. protein side chains (the N2 atom of His 66 and the O2
atom of Asp92) and two water molecules (W1 and W2).
W1 is hydrogen bonded to the O6 atom of the phosphateMetal Binding Site
group of calyculin A and to the hydroxyl oxygen ofAs mentioned above, we assumed the strong electron
densities located at the groove bifurcation to be Mn Tyr272. The O6 atom of the phosphate group also forms
Structure
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a hydrogen bond with W2. The O1 atom of Asp64 is the
axial ligand of M1. The coordination geometries around
both M1 and M2 are distorted square pyramids. M2
shares W2 and the O2 atom of Asp92 with M1 as the
bridging ligands for two metals. The four equatorial li-
gands of M2 are W2, the O2 atom of Asp92, the N2
atom of His173, and the N1 atom of His248. The axial
ligand of M2 is the O1 atom of Asn124. The average
distance between M1 and M2 is 3.2 A˚, which is similar
to that of PP1-MCLR.
At the active site, the metals, ligand atoms, water
molecules, and the phosphate group of calyculin A form
a close network (Figure 5A). W4 binds to the phosphate
O6 atom and the main chain N atom of Val250. The W3
oxygen atom forms hydrogen bonds with the phosphate
O7 atom and the N2 atom of His125, which supposedly
plays a critical role in the dephosphorylation reaction. Figure 6. Inhibitory Effects of Calyculin A and Hemicalyculin A of
The N2 of His125 forms a hydrogen bond with W5, PP1
which forms hydrogen bonds with N2 of Asn124, W2, The activity of PP1 (the total molar concentration, Et  2.0 nM)
and the O5 phosphate of calyculin A. The O5 phosphate was spectrophotometrically measured using pNPP (2 mM) as the
atom of calyculin A binds to the guanidyl group of Arg96 substrate. The ratios () of the steady-state activities in the presence
of calyculin A (circles) or hemicalyculin A (boxes) to the activity inand the hydroxyl group of Tyr272. The O6 atom of calyc-
their absence are plotted against the total concentration of theulin A forms a salt bridge with the side chain of Arg221.
inhibitors It (see Equation 1). Each symbol represents the averageAs a result, the phosphate group of calyculin A is firmly
of at least five values. Vertical bars indicating standard errors of
held by two salt bridges and six hydrogen bonds. means are shown if they are larger than the symbols. Note that the
inhibitory activity is considerably retained in hemicalyculin A, which
lacks the C29–C37 side chain. See the text for further details.
Calyculin A Binding Site in the Hydrophobic
and Acidic Grooves
As mentioned above, PP1 has three grooves on its mo- observed in the acidic groove. The region between C33
and C37 atoms of calyculin A, which is supposed tolecular surface, that is, the hydrophobic groove, the
acidic groove, and the C-terminal groove (Figure 3A). have large flexibility in the crystal form, could not be
located due to unclear electron densities.Calyculin A is located in the former two grooves through
the bifurcation point of the three grooves. The recogni- The data of the site-directed mutagenesis of PP1
showed that Tyr272 is of specific importance for thetion of calyculin A by the PP1 molecule is performed
by both hydrophobic and hydrophilic interactions. The binding of calyculin A [10] and that mutants N124D,
H248N, R96A, R221S, and D208A exhibit large de-recognition site formed by the grooves consists of Arg96
and Arg221. creases in sensivity to calyculin A [11]. As described
above, Tyr272, Arg96, and Arg221 bind to calyculin AHydrophobic interactions were observed between the
hydrophobic tail of calyculin A (N1–C10) and the hy- directly (Figures 5A and 5B), and the residues of Asn124
and His248 are the metal ligands and are included indrophobic groove of PP1. A similar interaction was ob-
served in the PP1-MCLR structure. Figure 5B shows the network at the active site (Figure 5A). Asp208 forms
a hydrogen bond with Arg221. It may contribute thethe residues located within 3.5 A˚ of calyculin A, except
for the metal ligand residues. The C49 and C50 atoms of stabilization of Arg221. Moreover, the other mutagene-
sis data reports that the mutant Y134F showed only acalyculin A show hydrophobic interactions with Val223.
The C10 and C46 atoms of calyculin A have van der slight difference of IC50 [16]. The fact that no hydrogen
bond exists between Tyr134 and calyculin A is consis-Waals contacts with Tyr134, which forms a hydrogen
bond with MCLR in the PP1-MCLR crystal structure. tent with this mutagenesis result.
Hydrophilic interactions are mainly observed in the
catalytic site of PP1, the bifurcation point of the three Inhibitory Effects of Calyculin A and Hemicalyculin
A on the p-Nitrophenol Phosphate (pNPP)grooves. The phosphate group of calyculin A forms salt
bridges with the side chains of the guanidyl groups of Phosphatase Activity of PP1
Figure 6 shows the inhibitory effects of calyculin A andArg96 and Arg221, as proposed for the substrate bound
to PP1 [20]. Hydrogen bonds between the phosphate hemicalyculin A on the phosphatase activity of PP1
measured using p-nitrophenyl phosphate (pNPP; 2 mM)oxygen and the phenol of Tyr272 and between 13-OH
of calyculin A and the guanidyl group of Arg221 were as the substrate. The specific activity of the preparation
of PP1 was 4.25  0.05 mol Pi liberated/min/mg ofobserved. 13-OH also forms an intramolecular hydrogen
bond with its phosphate oxygen. 11-OH of calyculin A protein (total number of measurements, n  195), which
was within the range of the value reported in our previousand the main chain carbonyl oxygen atom of Arg221 are
also hydrogen bonded. paper [19]. Calyculin A strongly inhibited this activity in
a dose-dependent manner (Figure 6). From the dose-In the acidic groove, the oxazole group exhibits a
weak contact with Asp220. Neither hydrogen bonds nor inhibition relationship, the Ki associated with the binding
of PP1 to calyculin A is estimated at 4.1  1 nM (n salt bridges between calyculin A and the enzyme were
Crystal Structure of the PP1-Calyculin A Complex
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123), which corresponds to a standard free-energy donating property of the 11-OH is dispensable because
calyculin J, with an ether oxygen on C11, retains thechange (G) of 48 kJ mol1. This Ki value is slightly
but significantly larger than the value (1.1 nM) obtained activity [8, 24]. Therefore, it is concluded that the hydro-
gen bond between 13-OH and Arg221 functions to keepby our previous experiments for the interaction of ca-
lyculin A and a native catalytic subunit of PP1 (PP1c) the phosphate group of calyculin A in a position distant
enough from the catalytic center. This assumption is inunder the same experimental conditions. Alessi et al.
[23] reported that the recombinant PP1 isozymes, in- accordance with the total loss of activity in the deriva-
tives modified at 13-OH [8].cluding PP1, were considerably less sensitive to oka-
daic acid and MCLR than PP1c. As they discussed, the Most of known protein phosphatase inhibitors exhibit
considerably higher affinity to PP2A than to PP1. Withaltered sensitivity presumably reflects conformational
differences between the expressed isozymes and native okadaic acid, for example, the ratio of the Ki value for
PP1 to that for PP2A (PP1/PP2A ratio) is about 5000PP1c.
The pNPP phosphatase activity of PP1 was also [19, 48, 49]. Although calyculin A also exhibits slightly
higher affinity for PP2A than it does for PP1, the differ-strongly inhibited by hemicalyculin A [8], which lacks
the C29–C37 component (Figures 1 and 6). The dose- ence in the affinities is much smaller with this toxin,
which gives a PP1/PP2A ratio of less than 10 [19]. Theinhibition data gave a Ki value of 14.8  0.5 nM (n  62),
which translates to a G of45 kJ mol1. The difference PP1/PP2A ratio corresponds to a difference in free-
energy change of less than 3 kJ/mol. A difference ofbetween the |G| for calyculin A and that for hemicalyc-
ulin A is thus only 3 kJ mol1. Considering the relatively this magnitude could be attributable to (for example) a
very small difference in the relative position of the donorlarge size of the C29–C37 component, which constitutes
about 30% of the total molecular mass of calyculin A, the and acceptor of a hydrogen bond. It is, unfortunately,
impossible to resolve such a small difference from thereduction of the affinity to PP1 caused by its removal is
surprisingly small. It is known that even slight modifica- present data. Further experiments are necessary to elu-
cidate the structural background for the widely differenttions of the rest of the molecule tend to cause a much
more drastic reduction of the affinity [8]. The C29–C37 affinities of the protein phosphatase inhibitors to PP1
and PP2A.component of calyculin A thus appears to make only a
limited contribution to the toxin binding to PP1. The
invisibility of the terminal amino acid portion in the X-ray
Biological Implicationscrystallography is indicative that this portion is exposed
to the solvent and has little or no interaction with the
The catalytic subunits of serine/threonine phosphatasesenzyme.
1 and 2A are subjected to inhibition by various toxins,
the so-called okadaic acid class of compounds [25],
including cyclic peptides based on compounds such asMechanism of PP1 Inhibition
The revised SAR study of calyculins has disclosed struc- MCLR [5], the polyketides, including okadaic acid [3]
and calyculin A [4], and terpenoids, including cantharidintural units important for the inhibition of PP1. Specifi-
cally, the loss of the phosphate group and the modifica- [6]. It has been shown that the okadaic acid class of
natural product inhibitors affects cellular reactions thattion of 13-OH abolished the inhibitory activity. While
isomerization of one or two double bonds in the hy- are controlled by phosphorylation/dephosphorylation
mechanisms and may promote tumor formation in somedrophobic tail diminished the activity to some extent,
the loss of the hydrophobic tail abrogated the activity. cases [2, 4, 26–33].
In the present study, we reported the first three-dimen-The crystal structure of the complex clearly showed the
importance of the salt bridges between the phosphate in sional structure of the calyculin A accommodated in
the catalytic subunit of serine/threonine phosphatase calyculin A and the two arginine residues in the substrate
recognition site. Similarly, the hydrophobic interactions (PP1). Numerous investigations of the binding model
of natural toxic inhibitors in PP1 have been carried outwere required to sustain the binding. However, these
interactions are not sufficient to explain the reason why based on the X-ray crystal structure of rabbit PP1 com-
plexed with MCLR (PP1-MCLR), as well as those ofthe phosphate group in calyculin A is resistant to hydro-
lysis by the enzyme. human PP1 and those of its complex with tungstate.
Therefore, the present structure of PP1-calyculin AThe catalytic mechanism proposed on the basis of
the structure of PP1 bound to tungstate dictates that complex provides direct evidence for understanding the
general mechanism of the PP1 inhibition. PP1 has twoO1 and O3 of the phosphate in the substrate form salt
bridges with Arg96 and Arg221, respectively, and O1 metal ions, which are located at the bifurcation point of
the Y-shaped grooves on the PP1 molecular surface.and O2 are bonded to the two metal ions so that the
hydroxide anion between the metals can attack the The phosphate group of calyculin A is also located at the
bifurcation point, and there are hydrophilic interactionsphosphorus atom [20]. In the complex of calyculin A and
PP1, in spite of the presence of the corresponding salt between PP1 and calyculin A. It therefore can be as-
sumed that the dephosphorylation reaction probablybridges of two phosphate oxygens with Arg96 and
Arg221, the atoms corresponding to O1 and O2 are occurs at this point. Between PP1 and calyclulin A,
there are hydrophilic interactions at the bifurcation pointmaintained in the position too far to be accessed by
the metals. It is likely that the remaining interaction(s) as well as hydrophobic interactions at the hydrophobic
groove. However, few interactions are observed at thebetween calyculin A and PP1 should keep the phosphate
group from approaching the metal ions. The hydrogen- acidic groove. The C-terminal groove of PP1 in PP1-
Structure
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generated by the program XPLO2D [40]. Two metal atoms were notcalyculin A complex is closed. The structures of PP1-
included in the refinement procedure to reduce the model bias incalyculin A complex, PP1-MCLR, and PP1-okadaic
the phases and were then added to the model in the last step toacid complex indicate that the hydrophobic groove
the center of the 20  peak in the Mn-omitted Fo  Fc electronplays a dominant role in binding the inhibitors and that density map. The superimpositions of the molecules were performed
the acidic groove does play an additional role. The struc- by using the program LSQMAN [41]. The final model was analyzed
using the program PROCHECK [42]. The charge distribution of theture of PP1 in complex with a phosphorylated protein will
molecular surface was calculated and represented by using the pro-provide information about how the C-terminal groove
gram GRASP [43]. The molecular models in the figures were drawnfunctions in molecular recognition.
by using the programs of MOLSCRIPT [44] and RASTER3D [45].
Experimental Procedures
Dose-Inhibition Analysis
The activity of the PP1 was measured at 25C using p-nitrophenylPreparation and Purification of Protein Phosphatases
phosphate (pNPP) as the substrate, essentially by the method de-A full-length cDNA encoding the  isoform of PP1 (PP1) was ex-
scribed previously [34]. This artificial substrate is particularly usefulpressed in Escherichia coli (provided by Dr. Patricia Cohen, Dundee,
for the present purpose because PP1 shows a considerably highUK), as described [23]. The expressed PP1was purified by sequen-
activity against it, which can be very easily and accurately measuredtial chromatography at 4C on five columns: HiPrep Q-XL, HiPrep
by monitoring the elevation of absorbance at 405 nm as a result ofSP-XL, phenyl-Sepharose, Sephacryl S-200, and Mono-Q (all pur-
liberation of the product p-nitrophenol. We have shown that thechased from Amersham-Pharmacia Biotech, Uppsala, Sweden).
pNPP phosphatase activity of PP1 exhibits essentially the sameBuffers used for the expression and purification of PP1 contained
susceptibilities to several phosphatase inhibitors (such as okadaic1 mM MnCl2. The purified sample of PP1 gave a single polypeptide
acid, microcystins, and tautomycin) and their derivatives as do itsspot at pH 6.0 and an apparent molecular mass of 37 kDa when
activities toward phosphorylated proteins [46, 47]. The buffer usedsubjected to two-dimensional electrophoresis (i.e., isoelectric fo-
for the assays contained the following: Tris-base, 40 mM; MgCl2,cusing on an IPG gel [Amersham-Pharmacia] in the presence of 8 M
34 mM; EDTA (free acid), 4 mM; and DL-dithiothreitol, 4 mM (pHurea and 20 mM DTT under a linear gradient of pH 3–10 in 10 cm,
8.4). No bivalent cation other than Mg2
 was added.which was followed by SDS/PAGE). The molar concentration of
In previous experiments on the inhibition of protein phosphatasesPP1 was determined by a titration procedure [34] using MCLR
by their tight binding inhibitors [19, 34, 48, 49], we have shown that(provided by Dr. K. Harada, Meijo University, Nagoya, Japan) as the
the steady-state dose-inhibition relationship at a fixed total enzymestandard.
concentration, Et, is well described by a general model function:
Crystallization
Purified protein solutions were dialyzed against 10 mM Tris-HCl (pH    (It ) 
Et  It  Ki 
 √(Et  It  Ki)2 
 4EtKi
2Et
(1)
7.8) containing 0.3 M NaCl, 0.2 mM MnCl2, and 3 mM dithiothreitol.
After dialysis of the protein solution, calyculin A was dissolved in
where Ki is the dissociation constant, and (It) denotes the fractionaldimethyl sulfoxiside (DMSO), mixed into a protein solution in the
activity at a given total inhibitor concentration, It. In the present3-fold excess with PP1, and incubated on ice for 1 hr. The sitting
experiments the Ki values were estimated with the standard errorsdrop vapor diffusion method was employed for the crystallization.
by fitting this nonlinear model function to the data obtained by dose-
The PP1-calyculin A solutions were concentrated to 7.4 mg/ml by
inhibition experiments.
using a microconcentrator (Centricon 30; Amicon). Droplets (2 l)
of the protein solution contained 7.4 mg/ml PP1-calyculin A, 10 mM
AcknowledgmentsTris-HCl (pH 7.8), 0.3 M NaCl, 0.2 mM MnCl2, and 3 mM dithiothreitol,
whereas the reservoir solutions contained 10 mM Tris-HCl (pH 7.8),
We would like to thank Drs. S. Adachi and S.-Y. Park of SPring-820% PEG 3350, and 0.2 M potassium sulfate. Mixtures of protein
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